Levosimendan added to dobutamine improved outcomes in patients with acute decompensated heart failure refractory to dobutamine alone (p=0.01).
Does levosimendan added to dobutamine improve outcomes in patients with acute decompensated heart failure refractory to dobutamine alone?
Levosimendan added to dobutamine may improve outcomes in acute decompensated heart failure refractory to dobutamine alone.
Absolute Event Rate: 0% vs 0%
= 0.01). In conclusion, levosimendan added to dobutamine may improve the outcome of ADHF refractory to dobutamine alone.
Juguet et al. (Mon,) reported a other. Levosimendan added to dobutamine improved outcomes in patients with acute decompensated heart failure refractory to dobutamine alone (p=0.01).